ReposiTrak Inkomsten in het verleden
Verleden criteriumcontroles 3/6
ReposiTrak heeft de winst zien groeien met een gemiddeld jaarlijks percentage van 17%, terwijl de Software-industrie de winst zag groeien met 31.8% per jaar. De inkomsten zijn gegroeid met een gemiddeld jaarlijks percentage van 3.5%. Het rendement op eigen vermogen van ReposiTrak is 14.4%, en het heeft een nettomarge van 30.1%.
Belangrijke informatie
17.05%
Groei van de winst
18.34%
Groei van de winst per aandeel
| Software Groei van de industrie | 17.33% |
| Inkomstengroei | 3.50% |
| Rendement op eigen vermogen | 14.43% |
| Nettomarge | 30.15% |
| Laatste winstupdate | 31 Mar 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Narratiefupdate • Jun 24
TRAK: Expanding Food Traceability Adoption Will Support Future Upside Potential
Analysts kept their fair value estimate for ReposiTrak steady at $16.00, with only minor adjustments to inputs such as the discount rate and future P/E. These changes fine tune their price target view rather than reshape it.Seeking Alpha • Jun 20
ReposiTrak: Walmart And Kroger May Prove The Bears Wrong
Summary ReposiTrak earns a buy rating, targeting $10.2/share by FY 2027, implying 11% upside after a sharp recent pullback. TRAK’s fundamentals remain solid, with profitability and operating leverage improving despite flat Q3 revenue due to FSMA compliance deadline timing shifts. Demand for TRAK’s traceability solutions appears robust, supported by retailer adoption and industry trends beyond regulatory requirements. Risks include slower-than-expected traceability adoption, but TRAK’s scalable SaaS model and regulatory tailwinds underpin an attractive risk-reward profile. Read the full article on Seeking AlphaNarratiefupdate • Jun 03
TRAK: Expanding Traceability And Compliance Adoption Will Support Future Upside Potential
Analysts have adjusted their price target on ReposiTrak to $16.00. The update reflects refreshed assumptions around revenue growth, profit margins, the discount rate and a slightly lower future P/E multiple.Narratiefupdate • May 05
TRAK: Expanding Food Traceability Adoption And Compliance Wins Will Drive Upside
Analysts have kept their ReposiTrak price target effectively unchanged at approximately $16.00, reflecting only very small tweaks in inputs such as discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their overall view of the stock. What's in the News A wholesale grocery cooperative in the Southern United States became the first wholesaler to reach full supplier to store traceability using ReposiTrak’s Touchless Traceability solution, achieving FSMA 204 compliance without case-level scanning or changes to distribution center workflows (Key Developments).Narratiefupdate • Apr 19
TRAK: Expanding Traceability Network Adoption Will Support Future Upside
Analysts held ReposiTrak's fair value estimate at $16.00 per share while making only very small tweaks to assumptions such as the discount rate and future P/E, reflecting largely unchanged views on the stock's risk and earnings profile. What's in the News ReposiTrak reported that eighteen fresh fruit and vegetable companies have joined the queue for the ReposiTrak Traceability Network to prepare for FDA Key Data Element sharing across their supply chains, covering a wide range of growers and distributors across the United States (Key Developments).Narratiefupdate • Apr 04
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have maintained their $16.00 price target on ReposiTrak, linking this steady view to only slight adjustments in discount rate and future P/E assumptions rather than any change in projected growth or profitability. What's in the News ReposiTrak and SPAR Group, Inc.Narratiefupdate • Mar 21
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have reaffirmed a $16.00 price target for ReposiTrak, citing only minimal tweaks to underlying assumptions such as discount rate, revenue growth, profit margin and future P/E, which together leave their overall valuation view effectively unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability is reported as the first to achieve end to end traceability under FDA FSMA Section 204, with hundreds of thousands of Key Data Element records generated across shipments, and several more corporate customers nearing similar go live milestones (Key Developments).Narratiefupdate • Mar 06
TRAK: Expanding Traceability Network And Share Buybacks Will Support Future Upside
Analysts have modestly reduced their price target on ReposiTrak to reflect a slightly lower future P/E assumption of 36.44x, while keeping key fair value and growth inputs broadly unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability has achieved end to end FSMA 204 traceability, generating hundreds of thousands of FDA Key Data Element records without case level scanning, with three more corporate customers close to similar go live points (Key Developments).Narratiefupdate • Feb 19
TRAK: Traceability Network Adoption Will Support Higher Future Profitability
Analysts have reduced their price target on ReposiTrak from $29 to $16, citing updated assumptions in their models for slower revenue growth, a lower future P/E multiple, and a higher profit margin profile. What's in the News ReposiTrak reported completing a share repurchase program announced on May 9, 2019, buying back a total of 2,220,026 shares, or 11.63% of the company, for US$14.46 million, including 79,927 shares, or 0.44%, repurchased between October 1, 2025 and December 31, 2025 for US$1.1 million (Key Developments).Analyse-artikel • Oct 01
Investors Will Want ReposiTrak's (NYSE:TRAK) Growth In ROCE To Persist
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...Analyse-artikel • Aug 02
Subdued Growth No Barrier To ReposiTrak, Inc.'s (NYSE:TRAK) Price
ReposiTrak, Inc.'s ( NYSE:TRAK ) price-to-earnings (or "P/E") ratio of 46.4x might make it look like a strong sell...Analyse-artikel • May 27
ReposiTrak's (NYSE:TRAK) Performance Is Even Better Than Its Earnings Suggest
ReposiTrak, Inc. ( NYSE:TRAK ) just reported healthy earnings but the stock price didn't move much. Investors are...Analyse-artikel • Apr 12
Earnings Not Telling The Story For ReposiTrak, Inc. (NYSE:TRAK)
With a price-to-earnings (or "P/E") ratio of 62.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...Analyse-artikel • Nov 09
ReposiTrak, Inc. (NYSE:TRAK) Not Lagging Market On Growth Or Pricing
With a price-to-earnings (or "P/E") ratio of 71.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...
Nieuw narratief • Oct 07
Critical Focus On Traceability Solutions Powers Revenue Growth And Profitability Surge
Emphasis on enhancing traceability solutions and strategic revenue focus predicts significant growth, with aims to improve net margins and year-over-year growth.Seeking Alpha • Oct 06
Track And Trace, But Don't Race: Why ReposiTrak Might Be Overvalued
Summary ReposiTrak shows solid growth potential with traceability services and recurring revenue but is currently overvalued with a high P/E ratio of 62.09x. Despite strong financials and profitability, rising operational expenses and heavy FDA dependency pose significant risks. Expansion into adjacent markets and AI-driven operational efficiencies are promising, but traceability revenue remains a small portion of the business. Given the speculative nature and high valuation, I recommend holding off on investing in ReposiTrak at this price. Read the full article on Seeking AlphaAnalyse-artikel • Jul 24
ReposiTrak, Inc.'s (NYSE:TRAK) P/E Is Still On The Mark Following 28% Share Price Bounce
ReposiTrak, Inc. ( NYSE:TRAK ) shareholders have had their patience rewarded with a 28% share price jump in the last...Analyse-artikel • Mar 23
ReposiTrak (NYSE:TRAK) Has More To Do To Multiply In Value Going Forward
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Analyse-artikel • Feb 28
Why Investors Shouldn't Be Surprised By ReposiTrak, Inc.'s (NYSE:TRAK) 28% Share Price Surge
Despite an already strong run, ReposiTrak, Inc. ( NYSE:TRAK ) shares have been powering on, with a gain of 28% in the...Opbrengsten en kosten
Opbrengsten en kosten
Hoe ReposiTrak geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 26 | 23 | 7 | 12 | 0 |
| 31 Dec 25 | 24 | 7 | 12 | 0 |
| 30 Sep 25 | 23 | 7 | 12 | 0 |
| 30 Jun 25 | 23 | 7 | 11 | 0 |
| 31 Mar 25 | 22 | 6 | 11 | 0 |
| 31 Dec 24 | 21 | 6 | 11 | 0 |
| 30 Sep 24 | 21 | 6 | 11 | 0 |
| 30 Jun 24 | 20 | 5 | 11 | 0 |
| 31 Mar 24 | 20 | 5 | 11 | 0 |
| 31 Dec 23 | 20 | 5 | 10 | 0 |
| 30 Sep 23 | 19 | 5 | 10 | 0 |
| 30 Jun 23 | 19 | 5 | 10 | 0 |
| 31 Mar 23 | 19 | 5 | 10 | 0 |
| 31 Dec 22 | 19 | 4 | 10 | 0 |
| 30 Sep 22 | 18 | 4 | 10 | 0 |
| 30 Jun 22 | 18 | 3 | 10 | 0 |
| 31 Mar 22 | 18 | 3 | 10 | 0 |
| 31 Dec 21 | 20 | 3 | 10 | 0 |
| 30 Sep 21 | 20 | 4 | 10 | 0 |
| 30 Jun 21 | 21 | 4 | 10 | 0 |
| 31 Mar 21 | 22 | 3 | 10 | 0 |
| 31 Dec 20 | 21 | 2 | 10 | 0 |
| 30 Sep 20 | 20 | 1 | 10 | 0 |
| 30 Jun 20 | 20 | 1 | 11 | 0 |
| 31 Mar 20 | 19 | 1 | 11 | 0 |
| 31 Dec 19 | 19 | 2 | 10 | 0 |
| 30 Sep 19 | 20 | 3 | 10 | 0 |
| 30 Jun 19 | 21 | 3 | 11 | 0 |
| 31 Mar 19 | 23 | 4 | 11 | 0 |
| 31 Dec 18 | 23 | 4 | 11 | 0 |
| 30 Sep 18 | 23 | 3 | 12 | 0 |
| 30 Jun 18 | 22 | 3 | 11 | 0 |
| 31 Mar 18 | 21 | 2 | 11 | 0 |
| 31 Dec 17 | 20 | 3 | 10 | 0 |
| 30 Sep 17 | 19 | 3 | 10 | 0 |
| 30 Jun 17 | 19 | 3 | 9 | 0 |
| 31 Mar 17 | 18 | 3 | 9 | 0 |
| 31 Dec 16 | 16 | 2 | 8 | 0 |
| 30 Sep 16 | 15 | 1 | 9 | 0 |
| 30 Jun 16 | 14 | 0 | 9 | 0 |
| 31 Mar 16 | 14 | -3 | 9 | 0 |
| 31 Dec 15 | 13 | -6 | 10 | 0 |
| 30 Sep 15 | 13 | -7 | 10 | 0 |
Kwaliteitswinsten: TRAK heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (30.1%) TRAK } zijn hoger dan vorig jaar (28.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van TRAK is de afgelopen 5 jaar met 17% per jaar gegroeid.
Versnelling van de groei: De winstgroei van TRAK over het afgelopen jaar ( 11.5% ) ligt onder het 5-jarig gemiddelde ( 17% per jaar).
Winst versus industrie: De winstgroei TRAK over het afgelopen jaar ( 11.5% ) overtrof de Software -sector 27.2%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 14.4% ) van TRAK wordt als laag beschouwd.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/13 06:06 |
| Aandelenkoers aan het einde van de dag | 2026/09/11 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/06/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
ReposiTrak, Inc. wordt gevolgd door 4 analisten. 1 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Thomas Forte | D.A. Davidson & Co. |
| Ananda Baruah | Loop Capital Markets |
| Thomas Forte | Maxim Group |